In these cases, the most commonly reported effects were gastrointestinal symptomsprimarily severe nausea, vomiting, and diarrheawhich can lead to dehydration and electrolyte disturbances if not managed appropriately
Short answer: almost certainly not
Quick refresher: Wegovy is approved by the Food and Drug Administration for chronic weight management in adults with either obesity (body mass index, or BMI, of 30+) or overweight (BMI of 27+) with at least one weight-related medical condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Interestingly, semaglutide remained stable for 3 hours at 80 degrees Celsius (176 degrees Fahrenheit) in controlled laboratory conditions, which suggests the molecule is fairly resilient to brief temperature spikes even at extreme levels
New England Journal of Medicine, 384(11), 9891002
Medical disclaimer: Lab testing provides health information but does not replace medication management, diagnosis, physical examination, imaging, or advice from a qualified healthcare provider